Global Pharmaceutical Fine Chemicals Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Pharmaceutical Fine Chemicals Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Basic building blocks
  • 1.4.3 Advanced intermediates
  • 1.4.4 Active ingredients
• 1.5 Market by Application
  • 1.5.1 Global Pharmaceutical Fine Chemicals Market Share by Application (2014-2025)
  • 1.5.2 Cardiovascular
  • 1.5.3 Neurology
  • 1.5.4 Oncology
  • 1.5.5 Infectious diseases
  • 1.5.6 Metabolic system
  • 1.5.7 Diabetes
  • 1.5.8 Respiratory disease
  • 1.5.9 Gastrointestinal diseases
  • 1.5.10 Musculoskeletal diseases
  • 1.5.11 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Pharmaceutical Fine Chemicals Market Size
• 2.2 Pharmaceutical Fine Chemicals Growth Trends by Regions
  • 2.2.1 Pharmaceutical Fine Chemicals Market Size by Regions (2014-2025)
  • 2.2.2 Pharmaceutical Fine Chemicals Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Pharmaceutical Fine Chemicals Market Size by Manufacturers
  • 3.1.1 Global Pharmaceutical Fine Chemicals Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Pharmaceutical Fine Chemicals Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Pharmaceutical Fine Chemicals Market Concentration Ratio (CR5 and HHI)
• 3.2 Pharmaceutical Fine Chemicals Key Players Head office and Area Served
• 3.3 Key Players Pharmaceutical Fine Chemicals Product/Solution/Service
• 3.4 Date of Enter into Pharmaceutical Fine Chemicals Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Pharmaceutical Fine Chemicals Market Size by Type (2014-2019)
• 4.2 Global Pharmaceutical Fine Chemicals Market Size by Application (2014-2019)

5 United States

• 5.1 United States Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 5.2 Pharmaceutical Fine Chemicals Key Players in United States
• 5.3 United States Pharmaceutical Fine Chemicals Market Size by Type
• 5.4 United States Pharmaceutical Fine Chemicals Market Size by Application

6 Europe

• 6.1 Europe Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 6.2 Pharmaceutical Fine Chemicals Key Players in Europe
• 6.3 Europe Pharmaceutical Fine Chemicals Market Size by Type
• 6.4 Europe Pharmaceutical Fine Chemicals Market Size by Application

7 China

• 7.1 China Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 7.2 Pharmaceutical Fine Chemicals Key Players in China
• 7.3 China Pharmaceutical Fine Chemicals Market Size by Type
• 7.4 China Pharmaceutical Fine Chemicals Market Size by Application

8 Japan

• 8.1 Japan Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 8.2 Pharmaceutical Fine Chemicals Key Players in Japan
• 8.3 Japan Pharmaceutical Fine Chemicals Market Size by Type
• 8.4 Japan Pharmaceutical Fine Chemicals Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 9.2 Pharmaceutical Fine Chemicals Key Players in Southeast Asia
• 9.3 Southeast Asia Pharmaceutical Fine Chemicals Market Size by Type
• 9.4 Southeast Asia Pharmaceutical Fine Chemicals Market Size by Application

10 India

• 10.1 India Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 10.2 Pharmaceutical Fine Chemicals Key Players in India
• 10.3 India Pharmaceutical Fine Chemicals Market Size by Type
• 10.4 India Pharmaceutical Fine Chemicals Market Size by Application

11 Central & South America

• 11.1 Central & South America Pharmaceutical Fine Chemicals Market Size (2014-2019)
• 11.2 Pharmaceutical Fine Chemicals Key Players in Central & South America
• 11.3 Central & South America Pharmaceutical Fine Chemicals Market Size by Type
• 11.4 Central & South America Pharmaceutical Fine Chemicals Market Size by Application

12 International Players Profiles

• 12.1 Angelini Acraf S.p.A.
  • 12.1.1 Angelini Acraf S.p.A. Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Pharmaceutical Fine Chemicals Introduction
  • 12.1.4 Angelini Acraf S.p.A. Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.1.5 Angelini Acraf S.p.A. Recent Development
• 12.2 W.R. Grace & Co.
  • 12.2.1 W.R. Grace & Co. Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Pharmaceutical Fine Chemicals Introduction
  • 12.2.4 W.R. Grace & Co. Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.2.5 W.R. Grace & Co. Recent Development
• 12.3 Kenko Corporation
  • 12.3.1 Kenko Corporation Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Pharmaceutical Fine Chemicals Introduction
  • 12.3.4 Kenko Corporation Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.3.5 Kenko Corporation Recent Development
• 12.4 Albemarle Corporation
  • 12.4.1 Albemarle Corporation Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Pharmaceutical Fine Chemicals Introduction
  • 12.4.4 Albemarle Corporation Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.4.5 Albemarle Corporation Recent Development
• 12.5 Denisco Chemicals
  • 12.5.1 Denisco Chemicals Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Pharmaceutical Fine Chemicals Introduction
  • 12.5.4 Denisco Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.5.5 Denisco Chemicals Recent Development
• 12.6 Chemada Fine Chemicals
  • 12.6.1 Chemada Fine Chemicals Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Pharmaceutical Fine Chemicals Introduction
  • 12.6.4 Chemada Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.6.5 Chemada Fine Chemicals Recent Development
• 12.7 Syntor Fine Chemicals
  • 12.7.1 Syntor Fine Chemicals Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Pharmaceutical Fine Chemicals Introduction
  • 12.7.4 Syntor Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.7.5 Syntor Fine Chemicals Recent Development
• 12.8 Johnson Matthey Fine Chemicals
  • 12.8.1 Johnson Matthey Fine Chemicals Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Pharmaceutical Fine Chemicals Introduction
  • 12.8.4 Johnson Matthey Fine Chemicals Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.8.5 Johnson Matthey Fine Chemicals Recent Development
• 12.9 Pfizer Inc
  • 12.9.1 Pfizer Inc Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Pharmaceutical Fine Chemicals Introduction
  • 12.9.4 Pfizer Inc Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.9.5 Pfizer Inc Recent Development
• 12.10 GlaxoSmithKline plc
  • 12.10.1 GlaxoSmithKline plc Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Pharmaceutical Fine Chemicals Introduction
  • 12.10.4 GlaxoSmithKline plc Revenue in Pharmaceutical Fine Chemicals Business (2014-2019)
  • 12.10.5 GlaxoSmithKline plc Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer